EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting SQLE-mediated cholesterol metabolism to enhance CD8 + T cell activation and immunotherapy efficacy in hepatocellular carcinoma

Shuang Qiao, Hao Zou, Yulan Weng, Yi-Fan Liu, Weihao Li, Xing-Juan Yu, Lian Li, Limin Zheng, Jing Xu

Journal for ImmunoTherapy of Cancer · 2025

DOI: 10.1136/jitc-2025-012345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2025. Verfasst von Shuang Qiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guan…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, CD8-Positive T-Lymphocytes, Cholesterol. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R&D Program of China, Guangdong Basic and Applied Basic Research Foundation, Guangdong Key-Area R&D Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The sustained effectiveness of anti-programmed cell death protein-1 (PD1) treatment is limited to a subgroup of patients with hepatocellular carcinoma (HCC) due to the tumor microenvironment heterogeneity, highlighting the need to identify targetable biomarkers that synergize with PD1 blockade. Abnormal cholesterol metabolism plays a critical role in HCC progression, along with growing evidence indicating its complex immunomodulatory effects within the tumor microenvironment. However, the interplay between cholesterol homeostasis and immune evasion remains elusive.

Methods

Transcriptomic and clinical data from HCC datasets were analyzed to identify cholesterol metabolism-related targets. Multiplex immunostaining and flow cytometry were applied to examine the immune landscape association with squalene epoxidase (SQLE) in human and murine tumors. Mechanistic studies were conducted in vitro, and co-culture experiments of tumor cells and T cells were followed by metabolomics and transcriptome analyses. Therapeutic efficacy was evaluated in mouse HCC models.

Results

We demonstrated that elevated SQLE expression in human HCC was associated with poor clinical outcomes and correlated with reduced CD8 + T cell infiltration and activation. Pharmacological inhibition or genetic knockdown of SQLE in tumor cells promoted CD8 + T cell proliferation and activation in co-culture experiments. Untargeted metabolomics identified 27-hydrocholesterol, an oxysterol derived from tumor cells, as a key factor impairing CD8 + T cell function via cholesterol dysregulation. SQLE inhibition in tumor cells suppressed oxysterols secretion, therefore overcoming cholesterol restrictions and enhancing the immune responses of CD8 + T cells. Moreover, SQLE targeting with terbinafine restored antitumor immunity and synergized with anti-PD1 therapy in HCC.

Conclusion

Targeting tumorous SQLE restores CD8 + T cell function by overcoming cholesterol restrictions via oxysterol-SREBP2 signaling, highlighting SQLE as a potential therapeutic target to enhance immunotherapy efficacy in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsCD8-Positive T-LymphocytesCholesterolImmunotherapySqualene MonooxygenaseHumansAnimalsMiceTumor MicroenvironmentLymphocyte ActivationCell Line, TumorFemaleMale

Stichwörter der Autor:innen

Hepatocellular CarcinomaTumor Microenvironment

Substanzen

CholesterolSqualene Monooxygenase

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Ministry of Education Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China xujing@sysucc.org.cn zhenglm@mail.sy…

Förderung

  • Key R&D Program of China
  • Guangdong Basic and Applied Basic Research Foundation
  • Guangdong Key-Area R&D Program
  • National Natural Science Foundation of China

Zitieren

APA

Qiao, S., Zou, H., Weng, Y., Liu, Y. F., Li, W., Yu, X. J., Li, L., Zheng, L., & Xu, J. (2025). Targeting SQLE-mediated cholesterol metabolism to enhance CD8 + T cell activation and immunotherapy efficacy in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-012345

Vancouver

Qiao S, Zou H, Weng Y, Liu YF, Li W, Yu XJ, et al. Targeting SQLE-mediated cholesterol metabolism to enhance CD8 + T cell activation and immunotherapy efficacy in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 2025. doi:10.1136/jitc-2025-012345

BibTeX
@article{Qiao2025,
  author = {Qiao, Shuang and Zou, Hao and Weng, Yulan and Liu, Yi-Fan and Li, Weihao and Yu, Xing-Juan and Li, Lian and Zheng, Limin and Xu, Jing},
  title = {Targeting SQLE-mediated cholesterol metabolism to enhance CD8 + T cell activation and immunotherapy efficacy in hepatocellular carcinoma},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  doi = {10.1136/jitc-2025-012345}
}
Kostenlos starten →